Longer-term therapy with omalizumab has been shown to improve asthma and reduce exacerbations. Investigators looked at the short-term effects of the medication.
In children and adolescents with asthma, concomitant rhinitis is ubiquitous and intractable. But how the conditions are related is incompletely understood.
Obesity is a risk factor for asthma, but new research from the European Respiratory Society International Congress suggests that the reverse is also true.
After assessing the occurrence rate of treatable traits in persons with severe asthma, researchers have determined which of these traits might be used to predict future asthma exacerbations.